Resistant depression associated with lupus erythematosus and steroid therapy.
Benazzi
F
F
D000368:Aged; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D015161:Dementia, Multi-Infarct / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D003866:Depressive Disorder / Q000175:diagnosis* / Q000188:drug therapy / Q000523:psychology; D003937:Diagnosis, Differential; D004351:Drug Resistance; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000523:psychology; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects*; D019965:Neurocognitive Disorders / Q000175:diagnosis* / Q000188:drug therapy / Q000523:psychology; D011605:Psychoses, Substance-Induced / Q000175:diagnosis* / Q000188:drug therapy / Q000523:psychology
D000928:Antidepressive Agents; D005938:Glucocorticoids; D008775:Methylprednisolone